Canopy Secures $22M Series B to Define the Standard for Connected Safety and Location Intelligence
Idomoo and Poppulo To Debut Dynamic AI-Driven In-Store Videos Powered by AWS at NRF
FedRAMP Authorized InEight Document Delivers a Faster Path to Secure Document Control for Federal Agencies and Contractors
Assassin’s Creed Leaps Into RAID: Shadow Legends Through Plarium and Ubisoft Partnership
SearchneedsLOVE Disrupts Digital Advertising Market with Global Launch of Accountability-Driven SEO Platform
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The…
MARLBOROUGH, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences , Inc. (Nasqad: AKYA)(“Akoya), The…
PRINCETON, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
PRINCETON, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…
DURHAM, N.C., Aug. 07, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
DURHAM, N.C., Aug. 07, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
LEXINGTON, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
LEXINGTON, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”)…
Seattle, Aug. 07, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
Seattle, Aug. 07, 2023 (GLOBE NEWSWIRE) — Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused…
MIAMI, Aug. 07, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
MIAMI, Aug. 07, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Company to host an investor conference call and webcast at 4:30pm EDT NEW YORK, Aug….
Company to host an investor conference call and webcast at 4:30pm EDT NEW YORK, Aug….
Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time YAVNE,…
Conference Call and Webcast Scheduled for Wednesday, August 16th at 8:30 am Eastern Time YAVNE,…